Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025
Same author

Evolutionary dynamics of HRSV following the implementation of nirsevimab immunoprophylaxis in Catalonia (2023-2024).

The Journal of infection·2025
Same author

Economic and healthcare resource utilization for hereditary transthyretin amyloidosis with polyneuropathy in Spain: real-world insights from early-stage patients and mutation carriers.

Expert review of pharmacoeconomics & outcomes research·2025
Same author

Unraveling the Amplification-Free Quantitative Detection of Viral RNA in Nasopharyngeal Swab Samples Using a Compact Electrochemical Rapid Test Device.

Analytical chemistry·2025
Same author

Biomarkers in transthyretin amyloidosis. Present and future.

Medicina clinica·2025
Same author

Management of Hereditary Transthyretin Amyloidosis (ATTRv) Patients and Asymptomatic Carriers in Spain: The EMPATIa Study.

Journal of clinical medicine·2025

Related Experiment Video

Updated: Jul 5, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

DNase 1 and systemic lupus erythematosus.

Fernando Martínez Valle1, Eva Balada, Josep Ordi-Ros

  • 1Research Unit in Systemic Autoimmune Diseases, Vall d'Hebron Research Institute, Hospital Vall d'Hebron, Passeig Vall d'Hebron 119-129, Barcelona, Spain.

Autoimmunity Reviews
|May 20, 2008
PubMed
Summary

Systemic lupus erythematosus (SLE) involves complex genetics and environmental factors. This review highlights the role of DNase1 enzyme in SLE pathophysiology, genetics, and potential therapies.

More Related Videos

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Related Experiment Videos

Last Updated: Jul 5, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Area of Science:

  • Immunology
  • Genetics
  • Biochemistry

Background:

  • Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a poorly understood genetic and environmental basis.
  • The enzyme DNase1 has been historically linked to SLE pathophysiology, particularly concerning the clearance of apoptotic debris.
  • Defects in apoptotic cell clearance can lead to the exposure of self-antigens, potentially triggering autoimmune responses in SLE.

Purpose of the Study:

  • To review current findings on the role of DNase1 in the pathophysiology of SLE.
  • To explore the genetic aspects of DNase1 in relation to SLE susceptibility.
  • To discuss the potential therapeutic implications of targeting DNase1 in SLE treatment.

Main Methods:

  • Literature review of existing studies on DNase1 and SLE.
  • Analysis of genetic associations between DNase1 and SLE.
  • Synthesis of data on DNase1's enzymatic function in apoptosis and immune response.

Main Results:

  • DNase1 plays a critical role in clearing apoptotic cellular material, preventing the release of self-antigens.
  • Genetic variations in DNase1 may contribute to SLE susceptibility.
  • Dysfunctional DNase1 activity is implicated in the autoimmune processes observed in SLE patients.

Conclusions:

  • DNase1 is a significant factor in SLE pathogenesis due to its role in apoptotic debris clearance.
  • Further research into DNase1 genetics and function could reveal novel therapeutic strategies for SLE.
  • Targeting DNase1 activity presents a promising avenue for SLE treatment development.